New combo sedation may ease scary lung scopes for kids

NCT ID NCT06755996

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a combination of two sedatives—dexmedetomidine nasal spray and remimazolam—in 150 children aged 2-6 years undergoing bronchoscopy. The goal was to see if this approach provides safe and effective sedation. Researchers measured how quickly children reached adequate sedation and how fast they woke up afterward.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dexmedetomidine and remimazolam

What this could lead to

If successful, this sedation approach could make pediatric bronchoscopy safer and more comfortable for children.

What could go wrong

This is a small, completed study without a control group, so results may not apply broadly. Risks include allergic reactions or side effects from the drugs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBEROPTIC BRONCHOSCOPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tongji hospital

    Wuhan, Hubei, 430030, China